[go: up one dir, main page]

GB0517092D0 - New compositions containing taxane derivatives - Google Patents

New compositions containing taxane derivatives

Info

Publication number
GB0517092D0
GB0517092D0 GB0517092A GB0517092A GB0517092D0 GB 0517092 D0 GB0517092 D0 GB 0517092D0 GB 0517092 A GB0517092 A GB 0517092A GB 0517092 A GB0517092 A GB 0517092A GB 0517092 D0 GB0517092 D0 GB 0517092D0
Authority
GB
United Kingdom
Prior art keywords
compositions containing
new compositions
taxane derivatives
containing taxane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0517092A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0517092A priority Critical patent/GB0517092D0/en
Publication of GB0517092D0 publication Critical patent/GB0517092D0/en
Priority to PCT/EP2006/008116 priority patent/WO2007020085A2/en
Priority to ARP060103597 priority patent/AR056465A1/en
Ceased legal-status Critical Current

Links

GB0517092A 2005-08-19 2005-08-19 New compositions containing taxane derivatives Ceased GB0517092D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0517092A GB0517092D0 (en) 2005-08-19 2005-08-19 New compositions containing taxane derivatives
PCT/EP2006/008116 WO2007020085A2 (en) 2005-08-19 2006-08-17 Compositions containing taxane derivatives for intravenous injection
ARP060103597 AR056465A1 (en) 2005-08-19 2006-08-17 COMPOSITIONS CONTAINING DERIVATIVES OF TAXANO

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0517092A GB0517092D0 (en) 2005-08-19 2005-08-19 New compositions containing taxane derivatives

Publications (1)

Publication Number Publication Date
GB0517092D0 true GB0517092D0 (en) 2005-09-28

Family

ID=35098012

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0517092A Ceased GB0517092D0 (en) 2005-08-19 2005-08-19 New compositions containing taxane derivatives

Country Status (3)

Country Link
AR (1) AR056465A1 (en)
GB (1) GB0517092D0 (en)
WO (1) WO2007020085A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2516056C (en) 2003-01-06 2012-05-29 Angiochem Inc. Aprotinin and analogs as carriers across the blood-brain barrier
BRPI0520032A2 (en) 2005-02-18 2009-04-14 Angiochem Inc molecules to carry a compound through the blood brain barrier
EP2471555A3 (en) 2005-07-15 2012-10-17 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
WO2007134354A1 (en) * 2006-05-23 2007-11-29 Ebewe Pharma Ges.M.B.H. Nfg. Kg Pharmaceutical formulation
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CN101327206B (en) * 2007-06-22 2011-07-20 成都市益斯生物科技有限公司 Docetaxel injection and preparation method thereof
AR063111A1 (en) * 2007-10-03 2008-12-30 Eriochem Sa A PHARMACEUTICAL FORMULATION OF TAXANO
KR101053780B1 (en) * 2008-02-29 2011-08-02 동아제약주식회사 Single liquid stable pharmaceutical composition containing docetaxel
EP2249839A4 (en) 2008-03-07 2013-10-16 Chemwerth Fulvestrant formulations
TR201905480T4 (en) * 2008-04-18 2019-05-21 Angiochem Inc Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and their respective preparation and use methods.
ES2344674B1 (en) * 2008-08-07 2011-06-29 Gp Pharm, S.A. INJECTABLE PHARMACEUTICAL COMPOSITION OF TAXANOS.
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
WO2010063122A1 (en) 2008-12-05 2010-06-10 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
CN102300987A (en) 2008-12-17 2011-12-28 安吉奥开米公司 Membrane Type-1 Matrix Metalloprotein Inhibitors And Uses Thereof
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
IN2012DN00248A (en) 2009-07-02 2015-05-01 Angiochem Inc
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US20120172796A1 (en) * 2010-12-30 2012-07-05 Chappa Ralph A Composition for intravascular delivery of therapeutic composition
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
US11179468B2 (en) 2012-04-09 2021-11-23 Eagle Pharmaceuticals, Inc. Fulvestrant formulations
DK2875814T3 (en) 2012-07-19 2018-11-12 Fujifilm Corp LIQUID COMPOSITION CONTAINING TAXAN-BASED ACTIVE INGREDIENT, PROCEDURE FOR PREPARING IT AND LIQUID PHARMACEUTICAL COMPOSITION
US9012665B2 (en) 2012-07-31 2015-04-21 Yung Shin Pharm. Ind. Co., Ltd. Amorphous cabazitaxel
WO2014028704A1 (en) * 2012-08-15 2014-02-20 Yung Shin Pharm. Ind. Co., Ltd. Stable pharmaceutical formulation of cabazitaxel
JP6285725B2 (en) * 2014-01-16 2018-02-28 ナガセ医薬品株式会社 Ethanol-free docetaxel pharmaceutical composition
CN107921143B (en) 2015-06-15 2021-11-19 安吉奥开米公司 Method for treating leptomeningeal carcinomatosis
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (en) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa NEW PHARMACEUTICAL COMPOSITIONS BASED ON DERIVATIVES OF THE TAXANE CLASS.
FR2698543B1 (en) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa New taxoid-based compositions.
CA2240595A1 (en) * 1995-12-21 1997-07-03 Bijan Almassian Taxane composition and method
AU2002239282A1 (en) * 2000-11-28 2002-06-11 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
KR20050099311A (en) * 2004-04-09 2005-10-13 에이엔에이치 케어연구소(주) Composition for injection comprising anticancer drug

Also Published As

Publication number Publication date
AR056465A1 (en) 2007-10-10
WO2007020085A3 (en) 2007-11-08
WO2007020085A2 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
GB0517092D0 (en) New compositions containing taxane derivatives
AP2008004547A0 (en) Petsticidal compositions
EP1906776A4 (en) Tobacco compositions
IL186721A0 (en) Bioenhanced compositions
ZA201305658B (en) Antiperspirant compositions
GB0503337D0 (en) Compositions
ZA200705428B (en) Stable prostaglandin-containing compositions
ZA200801174B (en) Antiperspirant compositions
IL186093A0 (en) Lignan-containing compositions
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
IL190321A0 (en) Compositions containing saratin
IL182126A0 (en) Compositions containing 5-phenoxyalkoxypsoralen derivatives
IL187552A0 (en) Pharmaceutical compositions containing nebivolol
PL1971320T3 (en) Antiperspirant compositions
GB0526283D0 (en) Compositions
GB0501365D0 (en) Compositions
ZA200709913B (en) Bioenhanced compositions
EP1849481A4 (en) Composition for external use
IL186252A0 (en) Pharmaceutical compositions containing melatonin derivatives
GB0524128D0 (en) Compositions
GB0502479D0 (en) Novel compositions
GB0502475D0 (en) Novel compositions
GB0525321D0 (en) Novel compositions
GB0526282D0 (en) Compositions
GB0524803D0 (en) Novel compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)